Efficacy and Safety of AQX-1125 in IC/BPS
Public ClinicalTrials.gov record NCT01882543. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Study identification
- NCT ID
- NCT01882543
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Aquinox Pharmaceuticals (Canada) Inc.
- Industry
- Enrollment
- 69 participants
Conditions and interventions
Conditions
Interventions
- AQX-1125 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2013
- Primary completion
- May 31, 2015
- Completion
- May 31, 2015
- Last update posted
- Sep 4, 2017
2013 – 2015
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AQX/CMX site | Homewood | Alabama | 35209 | — |
| AQX/CMX site | Glendora | California | 91741 | — |
| AQX/CMX site | San Diego | California | 92123 | — |
| AQX/CMX site | Denver | Colorado | 80211 | — |
| AQX/CMX site | Farmington | Connecticut | 06032 | — |
| AQX/CMX site | Orlando | Florida | 32801 | — |
| AQX/CMX site | Shreveport | Louisiana | 71106 | — |
| AQX/CMX site | Troy | Michigan | 48084 | — |
| AQX/CMX site | Garden City | New York | 11530 | — |
| AQX/CMX Site | Winston-Salem | North Carolina | 27103 | — |
| AQX/CMX site | Toledo | Ohio | 43615 | — |
| AQX/CMX site | DeSoto | Texas | 75115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01882543, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 4, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01882543 live on ClinicalTrials.gov.